Young Soo Lee Selected Research

Young Soo Lee Research Topics

Disease

10	Stroke (Strokes) 01/2023 - 05/2012
8	Atrial Fibrillation 01/2023 - 01/2015
6	Heart Failure 03/2020 - 02/2011
6	Inflammation (Inflammations) 05/2012 - 08/2003
5	Myocardial Infarction 01/2023 - 10/2013
4	Hemorrhage 01/2023 - 01/2015
4	Tachycardia (Tachyarrhythmias) 07/2022 - 07/2012
4	Sepsis (Septicemia) 10/2011 - 07/2009
3	Sarcopenia 01/2018 - 03/2016
3	Reperfusion Injury 01/2012 - 07/2006
3	Ischemia 01/2012 - 07/2006
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2012 - 07/2006
2	Cardiac Arrhythmias (Arrythmia) 04/2023 - 01/2020
2	Embolism (Embolus) 01/2023 - 08/2022
2	Hypertension (High Blood Pressure) 01/2022 - 03/2019
2	Cardiomyopathies (Cardiomyopathy) 11/2020 - 01/2017
2	Ventricular Fibrillation 03/2020 - 04/2013
2	Shock 03/2020 - 01/2017
2	Neoplasms (Cancer) 02/2020 - 08/2003
2	Heart Valve Diseases (Valvular Heart Disease) 02/2020 - 06/2017
2	Body Weight (Weight, Body) 03/2019 - 11/2018
2	Malnutrition (Nutritional Deficiencies) 01/2018 - 03/2016
2	Infarction (Infarctions) 01/2016 - 08/2009
2	Wounds and Injuries (Trauma) 05/2012 - 01/2006
2	Atherosclerosis 01/2011 - 11/2007
2	Endotoxemia 07/2009 - 02/2006
1	Heart Diseases (Heart Disease) 04/2023
1	Chronic Renal Insufficiency 01/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2023
1	Chronic Limb-Threatening Ischemia 01/2023
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 10/2018
1	Hypersensitivity (Allergy) 10/2018
1	Anaphylaxis (Anaphylactic Shock) 10/2018
1	Immediate Hypersensitivity 10/2018
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 10/2018
1	Drug Hypersensitivity (Drug Allergy) 10/2018
1	Persistent Left Superior Vena Cava 01/2018
1	Atrioventricular Nodal Reentry Tachycardia (AV Nodal Reentrant Tachycardia) 01/2018
1	Frailty 01/2018
1	Left Ventricular Dysfunction 01/2017
1	Cognitive Dysfunction 03/2016
1	Mitral Valve Insufficiency (Mitral Regurgitation) 03/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Ventricular Tachycardia 05/2013
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2012
1	Brain Infarction 05/2012
1	Brain Injuries (Brain Injury) 05/2012

Drug/Important Bio-Agent (IBA)

7	AnticoagulantsIBA 01/2023 - 01/2015
5	Heme Oxygenase-1IBA 05/2012 - 07/2006
5	HMGB1 Protein (HMG1)IBA 05/2012 - 07/2009
3	Warfarin (Coumadin)FDA LinkGeneric 01/2023 - 01/2020
3	Vitamin K FDA Link 08/2022 - 03/2019
3	higenamine (norcoclaurine)IBA 05/2012 - 02/2006
3	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2012 - 07/2006
3	LipopolysaccharidesIBA 06/2011 - 07/2009
3	Oxidants (Oxidizing Agents)IBA 11/2007 - 01/2006
2	Brain Natriuretic Peptide (Natrecor)FDA Link 03/2020 - 02/2011
2	N(4)-oleylcytosine arabinosideIBA 01/2020 - 03/2019
2	ApaminIBA 10/2013 - 04/2013
2	Carbon MonoxideIBA 06/2011 - 07/2009
2	tricarbonyldichlororuthenium (II) dimerIBA 12/2009 - 07/2009
2	AlkaloidsIBA 06/2004 - 08/2003
1	Carvedilol (Coreg)FDA LinkGeneric 04/2023
1	Polyvinyl Chloride (PVC)IBA 04/2023
1	Flecainide (Tambocor)FDA LinkGeneric 04/2023
1	Factor Xa InhibitorsIBA 01/2023
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2022
1	olmesartanIBA 01/2022
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2022
1	Dronedarone FDA Link 03/2019
1	CreatinineIBA 03/2019
1	Cephalosporins (Cephalosporin Antibiotics)IBA 10/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2018
1	Immunoglobulin E (IgE)IBA 10/2018
1	Cefaclor (Ceclor)FDA LinkGeneric 10/2018
1	GW 610742IBA 01/2016
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016
1	Therapeutic UsesIBA 01/2016
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2016
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2015
1	Thyroid HormonesIBA 03/2014
1	PotassiumIBA 10/2013
1	CalciumIBA 10/2013
1	Propafenone (Rythmol)FDA LinkGeneric 07/2012
1	Lidocaine (Xylocaine)FDA LinkGeneric 07/2012
1	Glucose (Dextrose)FDA LinkGeneric 05/2012

Therapy/Procedure

7	Therapeutics 01/2023 - 01/2015
3	Catheter Ablation 07/2022 - 05/2013
3	Ligation 10/2011 - 07/2009
3	Punctures 10/2011 - 07/2009
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 11/2020 - 01/2017
2	Secondary Prevention 03/2020 - 01/2017
2	Polypharmacy 01/2018 - 03/2016
2	Institutionalization (Institutionalized Persons) 01/2018 - 01/2018
1	Radiofrequency Ablation 07/2022
1	Denervation 01/2020
1	Wearable Electronic Devices 11/2018
1	Percutaneous Coronary Intervention 06/2017
1	Drug-Eluting Stents 03/2016